Psychiatry 73, 915923
A phase Ib study of linsitinib (OSI-906), a dual inhibitor of IGF-1R and IR tyrosine kinase, in combination with everolimus as treatment for patients with refractory metastatic colorectal cancer
Disclaimer: Information and statements regarding the product/services have not been evaluated by the Food and Drug Administration or any government authority and not intended to diagnose, treat, cure, or prevent any disease_ Product/Services reviews are provided by users based on their persona, experiences & opinions, and do not reflect the opinion of HealthKart_ Product/Services information provided by the seller on HealthKart is not exhaustive, please read the label on the product carefully for complete information provided by the manufacturer_ The results from the products will vary from person to person_ No individual result should be seen as typical_ Ranked: #243 in Vitamins & Supplements
Cellular methylation and metabolic signalling pathways
Thats where the top-rated weight loss solution in Hartford, CT comes in
References McDonald ES, Gillis LB, Gabriel P, et al